Music Therapy in Sickle Cell Transition Study

Completed · Not applicable

Conditions studied: Sickle Cell Disease

In brief

The purpose of this study is to investigate the effects of the BEATS Music Therapy Program on the self-efficacy, trust, knowledge, and adherence of young adult patients with sickle cell disease during transition. Primary Hypotheses: Compared to baseline, young adult patients with sickle cell disease who receive the music therapy interventions will report: 1. Higher sickle cell self-efficacy as measured by the Sickle Cell Self Efficacy Scale (SCSES), 2. Higher trust in health care providers as measured by the Wake Forest Trust in the Medical Profession Scale, and 3. Higher sickle cell disease knowledge as measured by the Seidman Sickle Cell Knowledge Quiz. Secondary Hypotheses 1\. Compared to the one year prior to the study period, young adults with sickle cell disease who receive the music therapy interventions will have a higher rate of adherence to clinic appointments during the one-year study period. Additional Questions 1. Do music therapy interventions influence attendance to scheduled blood transfusions? 2. Do music therapy interventions influence the rate of hospital utilization as measured by Emergency Department visits, Acute Care Clinic visits, and admissions during the study period compared to the previous year? 3. Do music therapy interventions influence adherence to hydroxyurea therapy for patients receiving hydroxyurea as measured by change in mean corpuscular volume (MCV) during the study period? 4. Do music therapy interventions influence adherence to iron chelation therapy for patients receiving iron chelation therapy as measured by ferritin count during the study period?

Key facts

Study ID

NCT02466555

Run by

University Hospitals Cleveland Medical Center

People needed

30

Starts

2015-06-01

Expected to finish

2016-08-01

Last updated by the study team

2019-09-13

Who can join

Age: 18 and older, up to 23. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject is between 18 and 23 years of age
• Subject is diagnosed with sickle cell disease
• Subject is able to speak and understand English
• Subject is currently scheduled for quarterly appointments in the Bridge Clinic

You may not qualify if…

• Subject has significant hearing impairment that has not been corrected
• Subject has significant visual impairment that has not been corrected

Where it is running

• University Hospitals Seidman Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.